InnaVirVax

InnaVirVax is developing at the clinical stage an innovating therapy for HIV infection that will act in synergy with antiretrovirals.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Évry, IDF, France
  • Currency EUR
  • Founded March 2008
  • Employees 10
  • Website innavirvax.fr

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free